Cel-Sci Corporation (CVM) vs Quantum Biopharma Ltd. (QNTM)

Cel-Sci Corporation and Quantum Biopharma Ltd. are both Biotechnology companies. Cel-Sci Corporation and Quantum Biopharma Ltd. are of similar size ($30.9M and $30.3M). Across the 12 metrics below, Cel-Sci Corporation leads on 9 and Quantum Biopharma Ltd. on 3.

Valuation

Metric CVM QNTM Biotechnology median
P/E n/m n/m 7.88
P/S 36.22 110.47 11.47
P/B 1.85 4.20 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 34.83 68.43 10.73
Earnings yield (68.40%) (142.60%) (28.84%)
Free cash flow yield (83.02%) (35.37%) (23.03%)

Profitability

Metric CVM QNTM Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (252.53%) (618.06%) (57.72%)
Return on assets (108.91%) (169.48%) (49.22%)
Return on invested capital (169.59%) 0.00% 0.00%

Growth

Metric CVM QNTM Biotechnology median
Revenue growth (TTM) 20.75% — 5.64%
EPS growth (last fiscal year) 59.06% 37.50% —
Revenue growth, 5-year CAGR 16.18% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CVM QNTM Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 1.48 1.20 4.73
Net debt to EBITDA 0.25 0.31 0.96

Dividend

Metric CVM QNTM Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CVM QNTM Biotechnology median
Market cap 30.25m 30.89m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack